<unk>  is an immunological agent that is FDA approved for the treatment of serious infections associated with Chronic Granulomatous Disease and delaying time to disease progression in patients with severe, malignant osteopetrosis.   Common adverse reactions include Injection site pain, rash, nausea, vomiting, arthralgia, myalgia, headache, fatigue, fever and influenza-like illness.
Interferon-gamma
Interleukin 13
Tumor necrosis factor-alpha
Leukotriene
Interleukin 27
Nitric oxide
TGF beta
Thromboxane